The inclusion of an atypical amino acid in their proteins allows Salmonella bacteria to resist certain antibiotics.
Until now, scientists thought that organisms used only α-amino acids to build their proteins. But Michael Ibba at Ohio State University in Columbus and his team have found that Salmonella make the structurally different β version of the amino acid lysine. In the bacteria, an enzyme called PoxA binds to β-lysine and passes it to the protein EF-P, which functions as a transfer-RNA mimic during protein synthesis. The researchers show that EF-P, a protein essential to Salmonella's virulence, is active only when it contains β-lysine.
Ibba's team think that the β-lysine-incorporation pathway could represent a new target for effective antibiotics against Salmonella.
Rights and permissions
About this article
Cite this article
Salmonella succeed in beta. Nature 476, 374–375 (2011). https://doi.org/10.1038/476374e
Published:
Issue Date:
DOI: https://doi.org/10.1038/476374e